Early diagnosis is fundamental for personalized prevention and effective therapeutic management, and in young non-obese individuals carrying MC4R monogenic mutations, an appropriate medical follow-up to prevent or at least delay the onset of obesity [122]. This evidence concerns the gene MC4R and obesity disorder.